Craft
Stemirna

Stemirna

Total Funding

$206.5 M

Stemirna Summary

Company summary

Overview
Stemirna is an RNA technology-based drug development company. It works on mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious diseases, protein defects diseases, and genetic diseases.
Type
Private
Founded
2016
HQ
Shanghai, CN | view all locations
Website
http://www.stemirna.com/en/index.aspx
Cybersecurity rating
Sectors

Key people

  • Hangwen Li

    Hangwen Li, Founder, President and Chief Executive Officer

  • Ming Deng

    Ming Deng, Vice General Manager

    • Jeffrey Zhang

      Jeffrey Zhang, Chief Operating Officer, Chief Business Officer

    Operating MetricsView all

    Patents Issued

    2

    May, 2020

    Patent Applications

    2

    May, 2020

    Partners

    4

    May, 2020

    LocationsView all

    1 location detected

    • Shanghai, Shanghai Shi HQ

      China

      room 603 - 604, building 2, 1295 Chuanqiao Rd, Pudong Xinqu

    Footer menu